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Abstract
Background: Basal TSH levels reflect the metabolic status of thyroid function, however the
definition and interpretation of the basal levels of TSH is a matter of controversial debate. The aim
of this study was to evaluate basal TSH levels in relation to the physiological response to i.v. TRH
stimulation.
Methods: A series of 2570 women attending a specialized endocrine unit were evaluated. A
standardized i.v. TRH stimulation test was carried out by applying 200 µg of TRH. TSH levels were
measured both in the basal and the 30 minute blood sample. The normal response to TRH
stimulation had been previously determined to be an absolute value lying between 2.5 and 20 mIU/
l. Both TSH values were analyzed by cross tabulation. In addition the results were compared to
reference values taken from the literature.
Results: Basal TSH values were within the normal range (0.3 to 3.5 mIU/l) in 91,5% of cases,
diminished in 3,8% and elevated in 4.7%. Based on the response to TRH, 82.4% were considered
euthyroid, 3.3% were latent hyperthyroid, and 14.3% were latent hypothyroid. Combining the data
on basal and stimulated TSH levels, latent hypothyroidism was found in the following proportions
for different TSH levels: 5.4% for TSH < 2.0 mIU/l, 30.2% for TSH between 2.0 and 3.0 mIU/l, 65,5%
for TSH between 3.0 and 3.50 mIU/l, 87.5% for TSH between 3.5 and 4.0 mIU/l, and 88.2% for TSH
between 4 and 5 mIU/l. The use of an upper normal range for TSH of 2.5 mIU/l, as recommended
in the literature, misclassified 7.7% of euthyroid cases.
Conclusion: Our analysis strategy allows us to delineate the predictive value of basal TSH levels
in relation to latent hypothyroidism. A grey area can be identified for values between 3.0 and 3.5
mIU/l.
Background
Elevated levels of TSH are the hallmark of decreased thy-
roid function. In order to correctly identify these patients
it is imperative to have a clear definition of the upper ref-
erence range for basal TSH. Patients whose TSH lies in the
upper reference range might appear to have minimal thy-
roid deficiency. Although this might appear to be an easy
task, the definition of the upper reference range for TSH
Published: 2 August 2007
BMC Endocrine Disorders 2007, 7:5 doi:10.1186/1472-6823-7-5
Received: 3 August 2006
Accepted: 2 August 2007
This article is available from: http://www.biomedcentral.com/1472-6823/7/5
© 2007 Moncayo et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 5
(page number not for citation purposes)
BMC Endocrine Disorders 2007, 7:5 http://www.biomedcentral.com/1472-6823/7/5has been matter of controversial debate [1-5]. Reported
reference values for the upper range of basal TSH vary
between 2.12 and 5.95 mIU/l [6-21] (Table 1). In the
majority of studies, the reference range for TSH has been
defined by statistical analysis (95% confidence interval)
of log transformed data. An alternative approach is to rely
on the physiological response of TSH to TRH stimulation
[22] taking the absolute TSH values 30 minutes after TRH
stimulation as the classification criteria [17,23,24].
Within the setting of a fertility unit, the exclusion or iden-
tification of causes of infertility requires a broad diagnos-
tic approach. In a recent review by Poppe, Velkeniers, and
Glinoer, special emphasis was put on the evaluation of
thyroid function [25]. Referring to thyroid function tests,
the authors commented the apparent discrepancy
between basal and TRH-stimulated TSH levels used to
detect subclinical hypothyroidism (Table 1 in [25]). The
aim of this retrospective study was to describe in more
detail the relation of basal TSH levels to the TRH-stimu-
lated levels and their validity for the detection of latent
hypothyroidism. Data analysis was also carried out in
comparison with criteria reported in the literature.
Methods
The laboratory methods used have been described else-
where [17]. A total of 2570 women attending the out-
patient unit for Reproductive Endocrinology at the Uni-
versity of Innsbruck were studied (mean age 31 years,
min. 21 years, max. 69 years). All patients were ambula-
tory and did not present any severe disease nor were tak-
ing any medication that could interfere with thyroid
function tests. Ninety percent of patients were consulting
the service due to irregularities of the menstrual cycle, or
infertility. Ten percent of cases corresponded to menopau-
sal women. Patients with known thyroid disease were
excluded. Informed consent was obtained according to
the Declaration of Helsinki. The study was approved by
the institutional Ethics Committee. The TRH test was car-
ried out by i.v. application of 200 µg of TRH. Both a basal
and a 30 minute blood sample were obtained. In the first
sample, both thyroid hormones (fT3 and fT4) and TSH
were determined; in the second one only TSH was meas-
ured. Antibody levels were not determined. The reference
values for basal TSH had been previously evaluated based
on ROC analysis and lied between 0.3 to 3.5 mIU/l [17].
These reference values will be called I-TSH in further com-
parisons. An absolute TSH increase between 2.5 and 20
mIU/l following TRH stimulation was defined as normal
[17]. The definition of these levels comes from a detailed
internal evaluation of both clinical and laboratory data of
2870 patients being investigated at the out-patient unit of
the Department of Nuclear Medicine, University of Inns-
bruck in 1993. The data from these patients was analyzed
in relation to age, gender, iodine excretion, scintigraphy,
sonography, and thyroid function tests (data not shown).
These criteria were also used in a later analysis of 12.838
subjects done 2003 [17]. Altogether a total of 15708 sub-
jects provide the foundation for the present analysis.
The reference ranges from the literature were taken from
Zöphel [19] and Baloch [26]. These will be referred to as
Z-TSH and B-TSH. A normal measured Z-TSH lies between
0.3 to 3.35 mIU/l, while a normal B-TSH has been pro-
posed to be between 0.4 to 2.5 mIU/l.
Table 1: Comparison of TSH reference levels from the literature
Author Year n Population Age in years TSH levels
De Rosa [6] 1996 259 12 – 82 0.3 – 3.32
Taimela [7] 1997 262 23 – 69 0.6 – 4.3
Bjoro [8] 2000 19327 f
9754 m
20–80 0.49 – 5.70 f
0.56 – 4.60 m
Steinmetz [9] 2000 1348 45–70 0.43 – 3.71
Hollowell [10] 2002 13344 12 – 80 0,45 – 4,12
Hubl [11] 2002 1030 18 – 90 0.19 – 4.25
Hübner [12] 2002 43 15–18 (study subgroup) 0.56 – 4.53
Gonzalez-Sagrado [13] 2004 304 12–94 0.51 – 5.95
Jensen [14] 2004 1512 17 – 66 0.58 – 4.07
D'Herbomez [15] 2005 710 18 – 65 0.35 – 3.48
Kratzsch [16] 2005 870 18 – 68 0.3 – 3.63
Moncayo [17] 2005 14981 20–89 0.3 – 3.5
Völzke [18] 2005 1488 20–79 0.25 – 2.12
Zöphel [19] 2005 1442 Unkown 0.3 – 3.35
Dhatt [20] 2006 959 16 – 75 0.3 – 4.32
O'Leary [21] 2006 2026 29 – 70 0.4 – 4.0
Total number of observations 69659Page 2 of 5
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The laboratory results were classified according to the cri-
teria presented by Dayan [27]. Statistical analysis (one
way ANOVA) was done with SPSS version 12. A p-value
less than 0.01 was called significant.
Results
Analysis of fT3 and fT4 and of basal TSH levels
Stratification of data according to age groups did not
reveal any age-dependency of thyroid function parameters
(fT3, fT4, or TSH; one way ANOVA, data not shown). The
classification of cases according to the levels of the free
thyroid hormone showed 86,65% of cases to lie within
the normal range, 2.3% lied above and 11.05% below.
The proportion of patients having a normal basal TSH
according to the 3 evaluation criteria was: 91.52% for I-
TSH, 90.66 for Z-TSH and 83.77 for B-TSH, respectively.
The lower number of euthyroid cases using the B-TSH cri-
teria was accompanied by a 7.76% increase in the propor-
tion of cases classified as having elevated TSH levels
(Table 2).
A cross tabulation analysis of both free thyroid hormones
and basal TSH (Table 3) showed that the normal ranges
for the I-TSH and Z-TSH criteria corresponded to 80 and
79,34% of the subjects who also had normal thyroid hor-
mone (TH) levels. In contrast to this, the proposed B-TSH
criteria recognized only 73,46% of cases with normal TH
levels as having a normal TSH. Again, the proposed B-TSH
criteria classified twice as many patients as the I-TSH and
Z-TSH criteria as hypothyroid/latent hypothyroid.
Analysis of the stimulated TSH levels
When the normal TSH response to TRH was compared to
basal TSH levels, 80.81% of cases were called normal
according to I-TSH, 80.54% for Z-TSH and 76.79% for B-
TSH. Comparing both TSH results, i.e. basal and stimu-
lated, an increasingly significant number of latent
hypothyroid patients could be found when basal TSH was
between 3 and 4. Latent hypothyroidism, defined as an
elevated TSH after TRH, was found in the following pro-
portions for different TSH levels: 5.4% for TSH < 2.0 mIU/
l, 30.2% for TSH between 2.0 and 3.0 mIU/l, 65,5% for
TSH between 3.0 and 3.50 mIU/l, 87.5% for TSH between
3.5 and 4.0 mIU/l, and 88.2% for TSH between 4 and 5
mIU/l (Figure 1).
Discussion
The environment of this study reflects a common situa-
tion encountered in modern medicine, i.e. a reference lab-
oratory will only have a blood sample for the biochemical
evaluation of the patient. For this reason, the clinical
validity of any test has to be evaluated in relation to the
physiology of the system being investigated. In the case of
thyroid physiology, the TRH test provides a physiological
insight of the metabolic state [22]. For this reason we used
Table 3: Cross tabulation for the categorized results according to 
free thyroid hormones and the TSH criteria. The figures in the 
table correspond to the percentage of cases from the total that 
fall within a specific category
Thyroid Hormones
b TSH low normal elevated
TSH Innsbruck < 0.3 n 8 71 19
% total 0,31 2,76 0,74
0.3 – 3.5 n 257 2056 39
% total 10 80 1,52
> 3.5 n 19 100 1
% total 0,74 3,89 0,04
TSH Zöphel < 0.3 n 8 71 19
% total 0,31 2,76 0,74
0.3 – 3.35 n 253 2039 38
% total 9,84 79,34 1,48
> 3.35 n 23 117 2
% total 0,89 4,55 0,08
TSHBaloch < 0.3 n 8 71 19
% total 0,31 2,76 0,74
0.3 – 2.5 n 231 1888 34
% total 8,99 73,46 1,32
> 2.5 n 45 268 6
% total 1,75 10,43 0,23
s TSH low normal elevated
Groups according 
to stimulated TSH 
values
< 2,5 n 7 60 19
% total 0,27 2,33 0,74
< 19,9 n 224 1857 36
% total 8,72 72,26 1,4
>= 20 n 53 310 4
% total 2,06 12,06 0,16
Table 2: Categorized results according to 4 classification criteria for normal: 1) basal TSH according to Innsbruck criteria (I-TSH), 2) 
TRH stimulated TSH levels (s-TSH), 3) basal TSH according to Zöphel (Z-TSH), 4) basal TSH according to Baloch (B-TSH). The 
figures in the table correspond to the percentage of cases from the total that fall within a specific category.
I-TSH % s-TSH % Z-TSH % B-TSH %
< 0.3 3,81 < 2,5 3,35 < 0.3 3,81 < 0.3 3,81
0.3 – 3.5 91,52 < 19,9 82,37 0.3 – 3.35 90,66 0.3 – 2.5 83,77
> 3.5 4,67 >= 20 14,28 > 3.35 5,53 > 2.5 12,41Page 3 of 5
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the evaluation of basal TSH levels in relation to the iden-
tification of latent and/or overt hypothyroidism. The nor-
mal range for TSH after TRH stimulation allowed us a
similar categorical classification of patients as done with
the values of free TH, thus underscoring the physiological
meaning of the TRH test. On the other hand, due to the
use of sensitive TSH assays, the identification of hyperthy-
roidism does not represent a problem, although in some
cases the determination of TSH alone can be deceiving
[27].
Recently, the proposition put forth by Baloch et al. [26] to
define the reference levels of TSH based on a preselected
(biased ?) population of healthy subjects has been inves-
tigated by Zöphel et al. [19]. In spite of adhering to
Baloch's theoretical postulate, they were not able to find a
difference in the reference levels for TSH using a pre-
selected or an unselected population [19]. Their result
shows, that pre-selection of normals based on thyroid
antibody titers and other parameters is not a requisite for
the definition of TSH levels. These conclusions apply to
our study. Interestingly the normal range defined by
Zöphel shows a good correlation with our results, those of
Baloch do not.
Several lines of evidence have appeared recently relating
altered body function in the presence of sub clinical
hypothyroidism making it relevant to be able to identify
such patients [28-32]. Since our study was purely diagnos-
tic, we can not compare our results to approaches that try
to analyze the cost-effectiveness of treating latent
hypothyroidism. On the other hand, the original setting
of this evaluation was predominantly related to problems
related to fertility, i.e. the field of reproductive endo-
crinology. Using a similar approach as ours, Raber et al.
have been able to show that infertility can be positively
influenced by thyroid hormone supplementation when
latent hypothyroidism is present [24]. Poppe et al. have
recently reviewed the relation between thyroid disease
and reproductive function in females. They have pointed
out that several strategies are used for the definition of the
upper level for TSH in order to detect subclinical hypothy-
roidism [25]. In their analysis, they suggest that data taken
from TRH-stimulation tests appear to be more sensitive
than other methods for defining normal TSH levels [25].
This situation is of outmost importance for pregnancy
outcome [33]. The use of risk population definitions
based on the presence of thyroid antibodies will miss a
significant number of women presenting overt/subclini-
cal hypothyroidism during early pregnancy [34]. Positive
thyroid antibodies in pregnant women might be a reflec-
tion of a Se deficiency state which requires supplementa-
tion in order to prevent thyroid disease [35]. In our
experience Se supplementation can also be beneficial in
cases of incipient thyroid disease [36] leading to a normal-
ization of both thyroid function parameters as well as of
thyroid function.
Conclusion
Our data analysis strategy supports a normal reference
range for TSH of 0.3 to 3.5 mIU/l. Either a clinical and lab-
oratory control or a TRH test can be recommended for
patients with basal TSH values lying between 3.0 and 3.5
mIU/l in order to rule out latent hypothyroidism.
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